Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 77 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

36%

28 trials in Phase 3/4

Results Transparency

6%

2 of 34 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

52Total
Not Applicable (8)
Early P 1 (2)
P 1 (10)
P 2 (4)
P 3 (13)
P 4 (15)

Trial Status

Completed34
Unknown27
Active Not Recruiting6
Not Yet Recruiting5
Recruiting3
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 34 completed trials

Clinical Trials (77)

Showing 20 of 20 trials
NCT07194668Phase 4Not Yet Recruiting

R21/MM Dosing, Presentations, and Preservatives

NCT04674462Phase 4Active Not RecruitingPrimary

Understanding Poor Vaccine Responses to Hepatitis B Vaccination

NCT06067555Early Phase 1RecruitingPrimary

Intradermal Influenza Vaccination

NCT05482295Phase 3Not Yet RecruitingPrimary

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)

NCT05546502Phase 3CompletedPrimary

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

NCT06986239Phase 1Not Yet RecruitingPrimary

Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant

NCT05431933Phase 3Completed

Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants

NCT05359250Completed

Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

NCT06888479Phase 3Not Yet Recruiting

Optimal Timing of Hepatitis B Vaccination After Transplants

NCT05598372Not ApplicableCompletedPrimary

Infant Pain During Vaccination and Maternal Anxiety

NCT05195151Not ApplicableCompleted

Modification of the COVID-19 Vaccine Response by an Intervention on the Intestinal Flora

NCT05825651Active Not Recruiting

Long COVID and Its Associations With Health Outcomes in Older Adults

NCT05098600Completed

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

NCT06690515Phase 1Not Yet Recruiting

Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants

NCT05028257Phase 3Completed

Allergy and COVID-19 Vaccines

NCT04922944Completed

Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients

NCT05923333Not ApplicableRecruiting

B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV

NCT06515938Not ApplicableCompletedPrimary

Study on New Strategies for Hepatitis B Virus Immunization

NCT06002503Phase 1Active Not RecruitingPrimary

Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection

NCT06142461Phase 2WithdrawnPrimary

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

Scroll to load more

Research Network

Activity Timeline